Uses
Technetium Tc 99m Mebrofenin is indicated as a hepatobiliary imaging agent.
Source: US FDA prescribing information
Molecule
Mebrofenin is a prescription medicine indicated as a hepatobiliary imaging agent. It is available as powder for injection for intravenous use. MedsAcross supplies Mebrofenin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
Technetium Tc 99m Mebrofenin is indicated as a hepatobiliary imaging agent.
Source: US FDA prescribing information
The suggested intravenous dose range of Technetium Tc 99m Mebrofenin in the average patient (70 kg) is: Nonjaundiced patient: 74-185 MBq (2-5 mCi) Patient with serum bilirubin level greater than 1.5 mg/dL: 111-370 MBq (3-10 mCi) The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration. The patient should be in a fasting state, 4 hours is preferable. False positives (non-visualization) may result if the gallbladder has been emptied by ingestion of food. An interval of at least 24 hours should be allowed before repeat examination. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.
Source: US FDA prescribing information
Hypersensitivity to this compound.
Source: US FDA prescribing information
The theoretical possibility of allergic reactions should be considered in patients who receive multiple doses.
Source: US FDA prescribing information
Urticaria and rash have been rarely reported with the use of Technetium Tc 99m Mebrofenin since market introduction. Rare cases of chills and nausea have been reported with related compounds. Infrequently, death has been reported in association with the use of this class of agents.
Source: US FDA prescribing information
Store the kit as supplied at 20-25°C (68-77°F) prior to and following reconstitution.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
2 presentations of Mebrofenin, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Mebrofenin 45 mg/10 mL powder for injectionIntravenousGeneric name | — | US FDA | Available on request |
| Choletec 45 mg powder for injectionIntravenous | Bracco Diagnostics | US FDA | Available on request |
1 brand names across 1 markets.
United States
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | Not recorded | — |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 2 presentations of Mebrofenin and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 1 brand names for Mebrofenin, including Choletec.
No listed presentation of Mebrofenin is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.